Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 11/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.35 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.35 |
| ▸ | GPR88 | Q9GZN0 | 2/20 | 0.34 |
| ▸ | XIAP | P98170 | 2/20 | 0.33 |
| ▸ | TACR1 | P25103 | 1/20 | 0.33 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24666318 | 1.00 | CFD (0.35) | CFDDPP4DPP8DPP7PSMB9 | |
| SCHEMBL24665935 | 0.91 | PSMB9 (0.34) | CFDPSMB9TACR1 | |
| SCHEMBL29230640 | 0.91 | PSMB9 (0.34) | CFDPSMB9TACR1 | |
| SCHEMBL29820473 | 0.91 | DPP4 (0.39) | CFDDPP4DPP8DPP7PSMB9 | |
| SCHEMBL24666477 | 0.91 | DPP4 (0.39) | CFDDPP4DPP8DPP7PSMB9 | |
| SCHEMBL24666103 | 0.85 | CFD (0.36) | CFDPSMB9XIAPTACR1ITGA4 | |
| SCHEMBL29230913 | 0.85 | CFD (0.36) | CFDPSMB9XIAPTACR1ITGA4 | |
| SCHEMBL24666057 | 0.85 | CFD (0.36) | CFDPSMB9XIAPTACR1ITGA4 | |
| SCHEMBL24666367 | 0.85 | PSMB9 (0.35) | CFDPSMB9TACR1 | |
| SCHEMBL29230689 | 0.85 | PSMB9 (0.35) | CFDPSMB9TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117956985-A | Inhibitors of glycogen synthase 1 (GYS 1) and methods of use thereof | 梅兹治疗公司 | 2024-04-30 | — | — | CN | disclosed |
| EP-4308095-A1 | INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF | Maze Therapeutics, Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| WO-2022198196-A1 | INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF | MAZE THERAPEUTICS, INC. (US) | 2022-09-22 | — | — | WO | disclosed |